Omthera Pharmaceuticals, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJul 18, 2013
- Shareholder vote · Other material eventJul 16, 2013
- Other material eventJul 9, 2013
- Other material eventJun 13, 2013
- Entered a material agreementMay 28, 2013
- Results of operations · Other material eventMay 28, 2013
- Director / officer changeApr 26, 2013
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BFORM 15-12BJul 29, 2013
- SC 13D/AOMTHERAJul 23, 2013
- S-8 POSFORM S-8 POSJul 22, 2013
- 8-KFORM 8-KJul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
- 4Jul 18, 2013
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.